Paydirt
NS
Insider

Namrata Saroj

Chief Business Officer

Namrata Saroj (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ocular Therapeutix, Inc. (OCUL). The largest single filing was $278K of OCUL (25,865 sh × $10.74, as filed), executed Nov 5 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$278K
shares × price, as filed
Last traded
Nov 5 2025
Filed Nov 7 2025

Median ADV $29.3M across their filed names

Open performance
Volume by month
$278K$139K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2025 · sells $278K
Buys $0 Sells $278K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
OCUL Ocular Therapeutix, Inc. OCUL · 0 buys · 1 sell 1 filing
Recent filings
OCULSALE Ocular Therapeutix, Inc. View filing → $278K
25,865 sh × $10.74
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET